Enamines
Sigma Aldrich Fine Chemicals Biosciences Amlodipine impurity G European Pharmacopoeia (EP) Reference Standard | 43067-01-2 | MFCD00194047 |
Amlodipine impurity G European Pharmacopoeia (EP) Reference Standard | Mol Wt: 335.78 | 43067-01-2 | MFCD00194047 |
Accela Chembio Inc Isopropyl 3-aminocrotonate | 100g | 14205-46-0 | MFCD00134272 | 97+% | Shelf Life: 1260 Days | Light Sensitive/+4
Isopropyl 3-aminocrotonate | 100g | 14205-46-0 | MFCD00134272 | 97+% | Shelf Life: 1260 Days | Light Sensitive/+4
Medchemexpress LLC (R)-Nimodipine | 77940-92-2 | 99.87% | 100 MG
(R)-Nimodipine is an orally active, blood-brain barrier-permeable L-type calcium channel blocker with an IC50 of 5 nM. It inhibits corticosterone release by blocking calcium channels on the hypothalamic-pituitary-adrenal axis, which can reverse immobilization stress-induced memory impairment and behavioral abnormalities. It is for research use only.
- Inhibits corticosterone release
- Reverses immobilization stress-induced memory impairment
- Used in studies related to aneurysmal subarachnoid hemorrhage
- Used in studies related to cerebral ischemia
- Used in studies related to epilepsy
- Used in studies related to age-related degenerative neurological diseases
- Used in studies related to alcohol intoxication
Apexbio Technology LLC Mesoridazine Besylate 32672-69-8 50mg
Mesoridazine besylate (CAS 32672-69-8) is a phenothiazine derivative that functions primarily as a dopamine receptor antagonist demonstrating notable inhibitory activity against dopamine D2 and D4 receptors The molecule has particularly high affinity toward the dopamine D4 receptor subtype By modulating dopamine receptor activity Mesoridazine besylate has potential relevance in neuroscience research aimed at understanding dopamine-mediated neurological pathways and disorders Frequently utilized in studies of psychotic conditions the compound serves as an important tool for investigating receptor-specific pharmacological mechanisms
Medchemexpress LLC (R)-Nimodipine | 77940-92-2 | 99.9% | 50 MG
(R)-Nimodipine is an orally active, blood-brain barrier-permeable L-type calcium channel blocker with an IC50 of 5 nM. It inhibits corticosterone release by blocking calcium channels on the hypothalamic-pituitary-adrenal axis, which can reverse immobilization stress-induced memory impairment and behavioral abnormalities.
- Used in studies related to aneurysmal subarachnoid hemorrhage
- Used in studies related to cerebral ischemia
- Used in studies related to epilepsy
- Used in studies related to age-related degenerative neurological diseases
- Used in studies related to alcohol intoxication
Sigma Aldrich Fine Chemicals Biosciences Nicardipine hydrochloride United States Pharmacopeia (USP) Reference Standard | 54527-84-3 | MFCD00057327 | 200MG
Nicardipine hydrochloride United States Pharmacopeia (USP) Reference Standard | Mol Wt: 515.99 | 54527-84-3 | MFCD00057327 | 200MG
Sigma Aldrich Fine Chemicals Biosciences Cilnidipine >=98% (HPLC), powder | 132203-70-4 | MFCD00865853 | 50MG
Cilnidipine >=98% (HPLC), powder | Purity: >=98% (HPLC) | Mol Wt: 492.52 | 132203-70-4 | MFCD00865853 | 50MG
Medchemexpress LLC Nimodipine | 66085-59-4 | 99.9% | 1 ML
Nimodipine is an orally active, well-tolerated, and light-sensitive dihydropyridine calcium antagonist. It is primarily used for the research of cerebrovascular disorders and is intended for research use only.
- Orally active and well-tolerated
- Light-sensitive dihydropyridine calcium antagonist
- Used in research for cerebrovascular disorders
- Available as a light yellow to yellow solid
- For research use only
Medchemexpress LLC Amlodipine maleate | 88150-47-4 | 99.9% | 5 G
Amlodipine maleate is a dihydropyridine calcium channel blocker that acts as an orally active antianginal agent. It blocks voltage-dependent L-type calcium channels, inhibiting the initial influx of calcium. This compound is used in research for high blood pressure and cancer studies.
- Blocks voltage-dependent L-type calcium channels
- Inhibits initial influx of calcium
- Attenuates uridine 5′-triphosphate (UTP)-induced increases of intracellular calcium
- Inhibits store-operated calcium influx
Apexbio Technology LLC Amlodipine Besylate 111470-99-6 10mM (in 1mL DMSO)
Amlodipine Besylate (CAS 111470-99-6) is a long-acting calcium channel blocker that reduces blood pressure primarily through inhibition of calcium ion influx via voltage-gated calcium channels Calcium channel modulation influences critical cellular signaling pathways In cortical neurons exposed to oxidative stress Amlodipine Besylate ( 5 M) preserves cellular viability by reducing oxidative damage enhancing pro-survival signals and suppressing apoptotic pathways It has also demonstrated proliferative effects on human epidermoid carcinoma (A431) cells Furthermore clinical studies indicate that Amlodipine Besylate decreases peripheral vascular resistance and myocardial oxygen demand in angina patients and effectively lowers arterial pressure in hypertensive feline models
Sigma Aldrich Fine Chemicals Biosciences Cisatracurium besylate Uni50MG
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.for further information and support please go to the website of the issuing Pharmacopoeia.
Sigma Aldrich Fine Chemicals Biosciences Nimodipine | 66085-59-4 | MFCD00153848 | 500MG
Nimodipine | Purity: >=98% (HPLC) | Mol Wt: 418.44 | 66085-59-4 | MFCD00153848 | 500MG
Medchemexpress LLC (R)-Amlodipine | 103129-81-3 | MFCD06809924 | 99.5% | 408.88 g/mol | C20H25ClN2O5 | 10 MG
(R)-Amlodipine is the R-enantiomer of amlodipine, a dihydropyridine L-type calcium channel inhibitor supplied as an off-white to light yellow solid for research use. It is commonly used in pharmacological and formulation studies that require the isolated enantiomer.
- High purity (99.45%).
- Molecular weight 408.88 g/mol.
- Chemical formula C20H25ClN2O5.
- Soluble in DMSO at 100 mg/mL; ultrasonic recommended.
- In vivo formulation protocols yield ≥2.5 mg/mL solubility in listed vehicles.
- Available in small research sizes (e.g., 10 mg).
- Storage: powder -20°C for up to 3 years; in solvent -80°C for 6 months or -20°C for 1 month.